The Value of Dihydrouracil/Uracil Plasma Ratios in Predicting 5-Fluorouracil-related Toxicity in Colorectal Cancer Patients

Author： Kristensen MH   Pedersen P   Mejer J  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.38, Iss.4, 2010-07, pp. : 1313-1323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tegafur/uracil less costly than fluorouracil in colorectal cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Tegafur/uracil less costly than fluorouracil in colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle

By LaBonte Melissa J   Lenz Heinz-Josef  

Pharmacogenomics, Vol. 14, Iss. 14, 2013-11 ,pp. : 1671-1674

Future Medicine

Access to resources Recommend Favorite

Variants in the Dihydropyrimidine Dehydrogenase, Methylenetetrahydrofolate Reductase and Thymidylate Synthase Genes Predict Early Toxicity of 5-Fluorouracil in Colorectal Cancer Patients

By Kristensen MH   Pedersen PL   Melsen GV   Ellehauge J   Mejer J  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 870-883

Field House Publishing

Access to resources Recommend Favorite

Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-283

Bentham Science Publishers

Access to resources Recommend Favorite